Nab-paclitaxel as First Line Treatment for NSCLC in Elderly Patients More Than 75 Years Old

Introduction: Lung cancer is still the leading cause of cancer among cancer patients. Although there are novel therapies as second line treatment for NSCLC, there is an issue for elderly patients. Patients and Methods: We collected retrospectively data from 60 patients >75 years of age. Thirty of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarogoulidis, Paul, Huang, Haidong, Bai, Chong, Petridis, Dimitris, Papadopoulou, Susana, Faniadou, Eleni, Eleftheriadou, Ellada, Trakada, Georgia, Cristoforos, Kosmidis, Rapti, Aggeliki, Yarmus, Lonny, Kopman, David-Feller, Man, Yan-Gao, Hohenforst-Schmidt, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535723/
https://www.ncbi.nlm.nih.gov/pubmed/28775787
http://dx.doi.org/10.7150/jca.19463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535723/
https://www.ncbi.nlm.nih.gov/pubmed/28775787
http://dx.doi.org/10.7150/jca.19463

Ejemplares similares